Embolization of Large and Giant Posterior Fossa Hemangioblastomas: The Experience of a Single Tertiary Care Center

Abstract

Background Hemangioblastomas pose an inherent surgical risk due to the potential for high intraoperative blood loss, especially in larger tumors. One approach to minimize this risk is to use preoperative embolization. Herein, we present our institutional experience treating large and giant cerebellar hemangioblastomas.

Methods We performed a retrospective chart review of 19 patients with cerebellar hemangioblastomas that had a maximal diameter of >3 cm. We performed a literature review and included individual patient-level data that met our >3 cm diameter cerebellar hemangioblastoma inclusion criteria.

Results Our cohort consisted of 19 patients that received a total of 20 resections for their cerebellar hemangioblastomas. Preoperative embolization was utilized in eight cases (38.1%). One patient experienced transient neurological complications after embolization (12.5%). Tumors of patients in the embolization group had larger median total, solid, and cystic volumes and were more likely to involve the cerebellopontine angle than those in the non-embolized group. Compared with non-embolized patients, embolized patients had less decrease in their hemoglobin, lower volumes of estimated blood loss, reduced rates of postoperative complications and permanent deficits, and greater instances of neurological improvement. The larger cohort (obtained from the combining our cohort with patients identified during a literature review) consisted of 99 patients with 39 receiving preoperative embolization.

Conclusion It is important to examine individual patient characteristics when determining eligibility for preoperative embolization. However, improvements in endovascular techniques have made preoperative embolization a safe and effective procedure with minimal risks that can be performed in many patients.

Keywords

cerebellar - hemangioblastoma - embolization - surgical outcomes - posterior fossa

Previous Presentations

North American Skull Base Society 31^st Annual Meeting, February 20, 2022, Phoenix, Arizona, United States.

^* Denotes co-first authors.

Publication History

Received: 15 July 2022

Accepted: 13 September 2022

Accepted Manuscript online:
16 September 2022

Article published online:
16 November 2022

• References

• 1 Jagannathan J, Lonser RR, Smith R, DeVroom HL, Oldfield EH. Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 2008; 108 (02) 210-222
• 2 Bründl E, Schödel P, Ullrich O-W, Brawanski A, Schebesch K-M. Surgical resection of sporadic and hereditary hemangioblastoma: our 10-year experience and a literature review. Surg Neurol Int 2014; 5: 138
• 3 Vortmeyer AO, Gnarra JR, Emmert-Buck MR. et al. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 1997; 28 (05) 540-543
• 4 Kanno H, Kondo K, Ito S. et al. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 1994; 54 (18) 4845-4847
• 5 Latif F, Tory K, Gnarra J. et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260 (5112): 1317-1320
• 6 Olschwang S, Richard S, Boisson C. et al. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma. Hum Mutat 1998; 12 (06) 424-430
• 7 Ampie L, Choy W, Lamano JB. et al. Safety and outcomes of preoperative embolization of intracranial hemangioblastomas: a systematic review. Clin Neurol Neurosurg 2016; 150: 143-151
• 8 Huang Y, Chan L, Bai HX. et al. Assessment of care pattern and outcome in hemangioblastoma. Sci Rep 2018; 8 (01) 11144
• 9 Zhou LF, Du G, Mao Y, Zhang R. Diagnosis and surgical treatment of brainstem hemangioblastomas. Surg Neurol 2005; 63 (04) 307-315 , discussion 315–316
• 10 Wan JQ, Cui H, Wang Y. Surgical management of large solid hemangioblastomas of the posterior fossa. J Clin Neurosci 2011; 18 (01) 39-42
• 11 Takeuchi S, Tanaka R, Fujii Y, Abe H, Ito Y. Surgical treatment of hemangioblastomas with presurgical endovascular embolization. Neurol Med Chir (Tokyo) 2001; 41 (05) 246-251 , discussion 251–252
• 12 Sakamoto N, Ishikawa E, Nakai Y. et al. Preoperative endovascular embolization for hemangioblastoma in the posterior fossa. Neurol Med Chir (Tokyo) 2012; 52 (12) 878-884
• 13 Shin GW, Jeong HW, Seo JH, Kim ST, Choo HJ, Lee SJ. Preoperative embolization of cerebellar hemangioblastoma with onyx: report of three cases. Neurointervention 2014; 9 (01) 45-49
• 14 Murai Y, Kominami S, Yoshida Y. et al. Preoperative liquid embolization of cerebeller hemangioblastomas using N-butyl cyanoacrylate. Neuroradiology 2012; 54 (09) 981-988
• 15 Munyon C, Chowdhry SA, Cohen ML, Bambakidis NC, Hsu DP. N-butyl 2-cyanoacrylate (n-BCA) embolization of a cerebellar hemangioblastoma. BMJ 2011; 3: 386-389
• 16 Montano N, Doglietto F, Pedicelli A. et al. Embolization of hemangioblastomas. J Neurosurg 2008; 108 (05) 1063-1064 , author reply 1064–1065
• 17 Tampieri D, Leblanc R, TerBrugge K. Preoperative embolization of brain and spinal hemangioblastomas. Neurosurgery 1993; 33 (03) 502-505 , discussion 505
• 18 Liao CC, Huang YH. Clinical features and surgical outcomes of sporadic cerebellar hemangioblastomas. Clin Neurol Neurosurg 2014; 125: 160-165
• 19 Abo-Al Hassan A, Ismail M, Panda SM. Pre-operative endovascular embolization of a cerebellar haemangioblastoma. A case report. Med Princ Pract 2006; 15 (06) 459-462
• 20 Fukuda M, Takao T, Hiraishi T. et al. Clinical factors predicting outcomes after surgical resection for sporadic cerebellar hemangioblastomas. World Neurosurg 2014; 82 (05) 815-821
• 21 Horvathy DB, Hauck EF, Ogilvy CS, Hopkins LN, Levy EI, Siddiqui AH. Complete preoperative embolization of hemangioblastoma vessels with Onyx 18. J Clin Neurosci 2011; 18 (03) 401-403
• 22 Gläsker S, Van Velthoven V. Risk of hemorrhage in hemangioblastomas of the central nervous system. Neurosurgery 2005; 57 (01) 71-76 , discussion 71–76
• 23 de San Pedro JR, Rodríguez FA, Níguez BF. et al. Massive hemorrhage in hemangioblastomas Literature review. Neurosurg Rev 2010; 33 (01) 11-26
• 24 Duffis EJ, Gandhi CD, Prestigiacomo CJ. et al; Society for Neurointerventional Surgery. Head, neck, and brain tumor embolization guidelines. J Neurointerv Surg 2012; 4 (04) 251-255
• 25 Liu AH, Peng TM, Wu Z. et al. Clinical effectiveness of preoperative embolization for cerebellar hemangioblastoma. Asian Pac J Cancer Prev 2013; 14 (09) 5179-5183
• 26 Sultan A, Hassan T, Aboul-Enein H, Mansour O, Ibrahim T. The value of preoperative embolization in large and giant solid cerebellar hemangioblastomas. Interv Neuroradiol 2016; 22 (04) 482-488
• 27 Sultan A, Hassan T, Aboul-Enein H, Mansour O, Ibrahim T. The value of preoperative embolization in large and giant solid cerebellar hemangioblastomas. Interv Neuroradiol 2016; 22 (04) 482-488
• 28 Shin GW, Jeong HW, Seo JH, Kim ST, Choo HJ, Lee SJ. Preoperative embolization of cerebellar hemangioblastoma with onyx: report of three cases. Neurointervention 2014; 9 (01) 45-49
• 29 Fukuda M, Takao T, Hiraishi T. et al. Clinical factors predicting outcomes after surgical resection for sporadic cerebellar hemangioblastomas. World Neurosurg 2014; 82 (05) 815-821